| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |